We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Abogen Biosciences

News List

Supported by Capital, the Application of mRNA Technology has Become a Hot Field in China PharmaSources/Xiaoyaowan
December 17, 2021
In the middle of August, Abogen Biosciences announced that it had completed a third round of financing with its total amount exceeding 700 million US dollars, which set a new record for single financing before IPO of Chinese biopharmaceutical companies.
GenScript ProBio, Abogen Biosciences and Walvax Biotechnology Enter into Collaboration on BLA and Commercial Manufacturing of mRNA Vaccine prnasia
November 30, 2021
GenScript ProBio, Suzhou Abogen Biosciences Technology Co. ("Abogen Biosciences") and Walvax Biotechnology Co. ("Walvax Biotechnology") announced a collaboration on commercial manufacturing...